Share Repurchase Programme

Summary by AI BETAClose X

Rights and Issues Investment Trust plc has reinstated its share repurchase programme for 12 months, commencing 27 March 2026, with a total value not exceeding £12.0 million. Cavendish Capital Markets Limited is authorised to repurchase ordinary shares, with monthly acquisitions capped at £1.0 million, though unused capacity can be carried forward. Purchases are restricted to a maximum price of 105% of the average closing prices over the preceding five dealing days, or 95% of the company's estimated net asset value per share. The company has confirmed it is not in possession of any inside information that would prevent this buyback.

Disclaimer*

Rights and Issues Inv. Trust PLC
27 March 2026
 

Rights and Issues Investment Trust plc ('the Company')

LEI:       2138002AWAM93Z6BP574

12 month Share Repurchase Programme in accordance with Discount Management Policy

Following the passing of the Special resolution authorising the Company to buy back shares at the Annual General Meeting held on 26 March 2026, Rights and Issues Investment Trust plc announces that the share repurchase programme which lapsed at the conclusion of the Annual General Meeting in 2025 has been reinstated with immediate effect for a period of 12 months to 26 March 2027. Cavendish Capital Markets Limited ("Cavendish") has been authorised to repurchase ordinary shares of 25p each ("Shares") on its behalf and within certain pre-set parameters between 27 March 2026 and 26 March 2027 (the "Buyback Period").

The Directors of the Company confirm that they are satisfied that all inside information known to the Directors and the Company up to the date of this notice has been notified to a Regulated Information Service ("RIS"). Accordingly, the Company is not prohibited from granting this authority to Cavendish under the Corporate Broking Agreement.

Purchases of Shares during the Buy-Back Period shall be subject to the following overriding restrictions:

(i)            the maximum number of Shares acquired shall not, in aggregate, exceed the authorities granted at the Company's annual general meeting in 2026.

(ii)           the maximum value of Shares acquired during the Buy-Back Period shall not exceed, in aggregate, £12.0 million. The maximum value of Shares acquired during each calendar month of the Buyback Period shall not, in aggregate, exceed £1.0 million (and pro rata for part months). However, to the extent that the value of Shares acquired in any month (or part month) is lower than the maximum value for that month, such excess capacity shall be carried forward to the following month and increase the maximum value for the following month accordingly, and so on for subsequent months. For the avoidance of doubt, there shall be no limit to the number of times an excess can be carried forward, or the total amount of such excess;

(iii)          the maximum price paid per Share shall be no more than the highest of: (i) 105% of the average middle market closing prices of the Shares for the 5 dealing days preceding the date of such purchase; (ii) the last independent trade price; and (iii) the highest current independent bid for the Shares when the purchase is carried out;

(iv)         the price paid per Share shall not be more than 95 per cent. of Cavendish's estimate of the net asset value per Share of the Company at the time of each purchase; and

(v)          no purchases are to be made on any dealing day when the Company appears on the Disclosure Table published by the Panel on Takeovers and Mergers.

The Company shall not (i) exercise any influence over how, when or whether Cavendish effects share repurchases or (ii) change the number of Shares, price or timing of the purchases.   

 

Enquiries:

Cavendish Capital Markets Limited


Andrew Worne / Tunga Chigovanyika - Corporate Finance          

+44 (0) 207 908 6000

Pauline Tribe - Sales      

+44 (0) 207 908 6000

Apex Fund Administration Services (UK) Limited

cosec-uk@apexgroup.com

+44 (0) 1245 398950

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings